Beyond Histology: A Dual-Cohort Genomic Analysis of 2901 Endometrial Carcinomas Reveals Class-Level Mismatch Repair Effects and Refines Molecular Classification.

Elif Sertesen Çamöz, Berkan Karabuğa, Cengiz Karaçin, Yunus Kasım Terzi, Zerrin Yılmaz Çelik

Abstract read

In one paragraph

Article in Genes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Elif Sertesen ÇamözDepartment of Medical Oncology, Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, University of Health Sciences, 06200 Ankara, Turkey.ORCID 0000-0002-1991-6620

Berkan KarabuğaDepartment of Medical Oncology, Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, University of Health Sciences, 06200 Ankara, Turkey.

Cengiz KaraçinDepartment of Medical Oncology, Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, University of Health Sciences, 06200 Ankara, Turkey.

Yunus Kasım TerziDepartment of Medical Genetics, Faculty of Medicine, Başkent University, 06790 Ankara, Turkey.ORCID 0000-0001-5612-9696

Zerrin Yılmaz ÇelikDepartment of Medical Genetics, Faculty of Medicine, Başkent University, 06790 Ankara, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

DNA Mismatch RepairEndometrial NeoplasmsCohort StudiesDNA-Binding ProteinsFemaleGenomicsHumansImmunotherapyMismatch Repair Endonuclease PMS2MutL Protein Homolog 1MutL ProteinsNeoplasm ProteinsNeoplasm StagingPrognosisTumor Suppressor Protein p53DNA-Binding ProteinsG-T mismatch-binding proteinMismatch Repair Endonuclease PMS2MLH1 protein, humanMutL Protein Homolog 1MutL ProteinsNeoplasm ProteinsPMS1 protein, humanPMS2 protein, humanTP53 protein, humanTumor Suppressor Protein p53clear cell carcinomaendometrial carcinomaLynch syndromemismatch repair deficiencymolecular classificationMSK-IMPACTPOLE mutationsurvivalTCGATP53tumor mutational burden

Identifiers

PMID42195047

DOI10.3390/genes17050591

PMCPMC13205493

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.